1. Home
  2. CTS vs AMPH Comparison

CTS vs AMPH Comparison

Compare CTS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • AMPH
  • Stock Information
  • Founded
  • CTS 1896
  • AMPH 1996
  • Country
  • CTS United States
  • AMPH United States
  • Employees
  • CTS N/A
  • AMPH N/A
  • Industry
  • CTS Electrical Products
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTS Technology
  • AMPH Health Care
  • Exchange
  • CTS Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • CTS 1.3B
  • AMPH 1.1B
  • IPO Year
  • CTS N/A
  • AMPH 2014
  • Fundamental
  • Price
  • CTS $41.89
  • AMPH $21.70
  • Analyst Decision
  • CTS
  • AMPH Hold
  • Analyst Count
  • CTS 0
  • AMPH 5
  • Target Price
  • CTS N/A
  • AMPH $38.00
  • AVG Volume (30 Days)
  • CTS 181.6K
  • AMPH 488.2K
  • Earning Date
  • CTS 07-29-2025
  • AMPH 08-06-2025
  • Dividend Yield
  • CTS 0.38%
  • AMPH N/A
  • EPS Growth
  • CTS 16.02
  • AMPH N/A
  • EPS
  • CTS 1.97
  • AMPH 2.77
  • Revenue
  • CTS $515,789,999.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • CTS $4.41
  • AMPH $0.67
  • Revenue Next Year
  • CTS $7.00
  • AMPH $5.18
  • P/E Ratio
  • CTS $21.35
  • AMPH $8.03
  • Revenue Growth
  • CTS N/A
  • AMPH 8.05
  • 52 Week Low
  • CTS $34.02
  • AMPH $21.48
  • 52 Week High
  • CTS $59.68
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • CTS 45.85
  • AMPH 28.01
  • Support Level
  • CTS $42.39
  • AMPH $22.81
  • Resistance Level
  • CTS $43.65
  • AMPH $23.77
  • Average True Range (ATR)
  • CTS 1.06
  • AMPH 0.76
  • MACD
  • CTS -0.16
  • AMPH -0.20
  • Stochastic Oscillator
  • CTS 24.94
  • AMPH 9.27

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: